_id
691720453c536f8df231687b
Ticker
TNYA
Name
Tenaya Therapeutics Inc
Exchange
NASDAQ
Address
171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.tenayatherapeutics.com
Description
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. The company's lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in phase 2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in phase 1 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. The company develops its products through gene editing, cellular regeneration, gene silencing, and gene addition. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Last Close
1.36
Volume
1594578
Current Price
0.85
Change
-37.50000000000001
Last Updated
2025-12-04T14:18:13.000Z
Image
https://logo.clearbit.com/www.tenayatherapeutics.com
Ipo Date
2021-07-30T00:00:00.000Z
Market Cap
221452832
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.8915
Sentiment Sources
2
Rating
4.6667
Target Price
10.1429
Strong Buy
6
Buy
3
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
1864000
Gross Profit
-1864000
Operating Expenses
19072000
Operating Income
-20936000
Interest Expense
-
Pretax Income
-20275000
Net Income
-20275000
Eps
-0.12412304847039632
Dividends Per Share
-
Shares Outstanding
166505885
Income Tax Expense
-
EBITDA
-18411000
Operating Margin
-
Total Other Income Expense Net
661000
Cash
56312000
Short Term Investments
0
Receivables
-
Inventories
-
Total Current Assets
61239000
Property Plant Equipment
39497000
Total Assets
104980000
Payables
2843000
Short Term Debt
2926000
Long Term Debt
-
Total Liabilities
22112000
Equity
82868000
Depreciation
1864000
Change In Working Capital
-921000
Cash From Operations
-15599000
Capital Expenditures
26000
Cash From Investing
8860000
Cash From Financing
380000
Net Change In Cash
-6359000
PE
-
PB
1.6754848216440605
ROE
-24.46662161509871
ROA
-19.313202514764715
FCF
-15625000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
3.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
3
Net Net Investing Score
3
Quality Investing Score
2.5
Value Investing Score
4
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
1864000
Quarters > 0 > income Statement > gross Profit
-1864000
Quarters > 0 > income Statement > operating Expenses
19072000
Quarters > 0 > income Statement > operating Income
-20936000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-20275000
Quarters > 0 > income Statement > net Income
-20275000
Quarters > 0 > income Statement > eps
-0.12412304847039632
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
163345972
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-18411000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
661000
Quarters > 0 > balance Sheet > cash
56312000
Quarters > 0 > balance Sheet > short Term Investments
0
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
61239000
Quarters > 0 > balance Sheet > property Plant Equipment
39497000
Quarters > 0 > balance Sheet > total Assets
104980000
Quarters > 0 > balance Sheet > payables
2843000
Quarters > 0 > balance Sheet > short Term Debt
2926000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
22112000
Quarters > 0 > balance Sheet > equity
82868000
Quarters > 0 > cash Flow > net Income
-20275000
Quarters > 0 > cash Flow > depreciation
1864000
Quarters > 0 > cash Flow > change In Working Capital
-921000
Quarters > 0 > cash Flow > cash From Operations
-15599000
Quarters > 0 > cash Flow > capital Expenditures
26000
Quarters > 0 > cash Flow > cash From Investing
8860000
Quarters > 0 > cash Flow > cash From Financing
380000
Quarters > 0 > cash Flow > net Change In Cash
-6359000
Quarters > 0 > ratios > PE
-0.12412304847039632
Quarters > 0 > ratios > PB
1.6754848216440605
Quarters > 0 > ratios > ROE
-24.46662161509871
Quarters > 0 > ratios > ROA
-19.313202514764715
Quarters > 0 > ratios > FCF
-15625000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
2084000
Quarters > 1 > income Statement > gross Profit
-2084000
Quarters > 1 > income Statement > operating Expenses
21998000
Quarters > 1 > income Statement > operating Income
-24082000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-23283000
Quarters > 1 > income Statement > net Income
-23283000
Quarters > 1 > income Statement > eps
-0.14302336854905745
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
162791579
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-21199000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
799000
Quarters > 1 > balance Sheet > cash
62671000
Quarters > 1 > balance Sheet > short Term Investments
8996000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
75875000
Quarters > 1 > balance Sheet > property Plant Equipment
41967000
Quarters > 1 > balance Sheet > total Assets
122151000
Quarters > 1 > balance Sheet > payables
3297000
Quarters > 1 > balance Sheet > short Term Debt
2834000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
22323000
Quarters > 1 > balance Sheet > equity
99828000
Quarters > 1 > cash Flow > net Income
-23283000
Quarters > 1 > cash Flow > depreciation
2384000
Quarters > 1 > cash Flow > change In Working Capital
1007000
Quarters > 1 > cash Flow > cash From Operations
-15613000
Quarters > 1 > cash Flow > capital Expenditures
142000
Quarters > 1 > cash Flow > cash From Investing
24988000
Quarters > 1 > cash Flow > cash From Financing
-476000
Quarters > 1 > cash Flow > net Change In Cash
8899000
Quarters > 1 > ratios > PE
-0.14302336854905745
Quarters > 1 > ratios > PB
1.3861125350603036
Quarters > 1 > ratios > ROE
-23.32311575910566
Quarters > 1 > ratios > ROA
-19.060834540855172
Quarters > 1 > ratios > FCF
-15755000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
43
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
27538000
Quarters > 2 > income Statement > operating Income
-27538000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-26864000
Quarters > 2 > income Statement > net Income
-26864000
Quarters > 2 > income Statement > eps
-0.24450875157293744
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
109869278
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-24877000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
674000
Quarters > 2 > balance Sheet > cash
53772000
Quarters > 2 > balance Sheet > short Term Investments
34386000
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
94485000
Quarters > 2 > balance Sheet > property Plant Equipment
44654000
Quarters > 2 > balance Sheet > total Assets
143952000
Quarters > 2 > balance Sheet > payables
5064000
Quarters > 2 > balance Sheet > short Term Debt
2794000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
24556000
Quarters > 2 > balance Sheet > equity
119396000
Quarters > 2 > cash Flow > net Income
-26864000
Quarters > 2 > cash Flow > depreciation
2661000
Quarters > 2 > cash Flow > change In Working Capital
-3435000
Quarters > 2 > cash Flow > cash From Operations
-23112000
Quarters > 2 > cash Flow > capital Expenditures
383000
Quarters > 2 > cash Flow > cash From Investing
22302000
Quarters > 2 > cash Flow > cash From Financing
50259000
Quarters > 2 > cash Flow > net Change In Cash
49449000
Quarters > 2 > ratios > PE
-0.24450875157293744
Quarters > 2 > ratios > PB
0.7821776801567891
Quarters > 2 > ratios > ROE
-22.499916245100337
Quarters > 2 > ratios > ROA
-18.66177614760476
Quarters > 2 > ratios > FCF
-23495000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
24652000
Quarters > 3 > income Statement > operating Income
-24652000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-23836000
Quarters > 3 > income Statement > net Income
-23836000
Quarters > 3 > income Statement > eps
-0.2758602427847895
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
86406072
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-22563000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
816000
Quarters > 3 > balance Sheet > cash
4323000
Quarters > 3 > balance Sheet > short Term Investments
57123000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
67375000
Quarters > 3 > balance Sheet > property Plant Equipment
47748000
Quarters > 3 > balance Sheet > total Assets
119940000
Quarters > 3 > balance Sheet > payables
5162000
Quarters > 3 > balance Sheet > short Term Debt
2778000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
27086000
Quarters > 3 > balance Sheet > equity
92854000
Quarters > 3 > cash Flow > net Income
-23836000
Quarters > 3 > cash Flow > depreciation
2089000
Quarters > 3 > cash Flow > change In Working Capital
-1036000
Quarters > 3 > cash Flow > cash From Operations
-18388000
Quarters > 3 > cash Flow > capital Expenditures
204000
Quarters > 3 > cash Flow > cash From Investing
14103000
Quarters > 3 > cash Flow > cash From Financing
377000
Quarters > 3 > cash Flow > net Change In Cash
-3908000
Quarters > 3 > ratios > PE
-0.2758602427847895
Quarters > 3 > ratios > PB
0.7909746612962284
Quarters > 3 > ratios > ROE
-25.670407306093434
Quarters > 3 > ratios > ROA
-19.87326996831749
Quarters > 3 > ratios > FCF
-18592000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
8468000
Annuals > 0 > income Statement > gross Profit
-8468000
Annuals > 0 > income Statement > operating Expenses
107480000
Annuals > 0 > income Statement > operating Income
-115948000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-111129000
Annuals > 0 > income Statement > net Income
-111129000
Annuals > 0 > income Statement > eps
-1.310143594822098
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
84822000
Annuals > 0 > income Statement > income Tax Expense
-111129000
Annuals > 0 > income Statement > EBITDA
-102661000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
4819000
Annuals > 0 > balance Sheet > cash
4323000
Annuals > 0 > balance Sheet > short Term Investments
57123000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
67375000
Annuals > 0 > balance Sheet > property Plant Equipment
47748000
Annuals > 0 > balance Sheet > total Assets
119940000
Annuals > 0 > balance Sheet > payables
5162000
Annuals > 0 > balance Sheet > short Term Debt
2778000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
27086000
Annuals > 0 > balance Sheet > equity
92854000
Annuals > 0 > cash Flow > net Income
-111129000
Annuals > 0 > cash Flow > depreciation
8468000
Annuals > 0 > cash Flow > change In Working Capital
-7931000
Annuals > 0 > cash Flow > cash From Operations
-90501000
Annuals > 0 > cash Flow > capital Expenditures
1025000
Annuals > 0 > cash Flow > cash From Investing
1131000
Annuals > 0 > cash Flow > cash From Financing
47749000
Annuals > 0 > cash Flow > net Change In Cash
-41621000
Annuals > 0 > ratios > PE
-1.310143594822098
Annuals > 0 > ratios > PB
1.2149531522605381
Annuals > 0 > ratios > ROE
-119.68143537165874
Annuals > 0 > ratios > ROA
-92.65382691345673
Annuals > 0 > ratios > FCF
-91526000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
35
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
8687000
Annuals > 1 > income Statement > gross Profit
-8687000
Annuals > 1 > income Statement > operating Expenses
122506000
Annuals > 1 > income Statement > operating Income
-131193000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-124084000
Annuals > 1 > income Statement > net Income
-124084000
Annuals > 1 > income Statement > eps
-1.681671158613206
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
73786126
Annuals > 1 > income Statement > income Tax Expense
8519105
Annuals > 1 > income Statement > EBITDA
-115397000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
7109000
Annuals > 1 > balance Sheet > cash
45681000
Annuals > 1 > balance Sheet > short Term Investments
58961000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
111582000
Annuals > 1 > balance Sheet > property Plant Equipment
53256000
Annuals > 1 > balance Sheet > total Assets
170515000
Annuals > 1 > balance Sheet > payables
5630000
Annuals > 1 > balance Sheet > short Term Debt
4319000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
31091000
Annuals > 1 > balance Sheet > equity
139424000
Annuals > 1 > cash Flow > net Income
-124084000
Annuals > 1 > cash Flow > depreciation
8687000
Annuals > 1 > cash Flow > change In Working Capital
-5648000
Annuals > 1 > cash Flow > cash From Operations
-102072000
Annuals > 1 > cash Flow > capital Expenditures
1239000
Annuals > 1 > cash Flow > cash From Investing
48715000
Annuals > 1 > cash Flow > cash From Financing
4049000
Annuals > 1 > cash Flow > net Change In Cash
-49308000
Annuals > 1 > ratios > PE
-1.681671158613206
Annuals > 1 > ratios > PB
0.7038640949908195
Annuals > 1 > ratios > ROE
-88.99759008492082
Annuals > 1 > ratios > ROA
-72.77013752455795
Annuals > 1 > ratios > FCF
-103311000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
8713000
Annuals > 2 > income Statement > gross Profit
-8713000
Annuals > 2 > income Statement > operating Expenses
125621000
Annuals > 2 > income Statement > operating Income
-125621000
Annuals > 2 > income Statement > interest Expense
1956
Annuals > 2 > income Statement > pretax Income
-123665000
Annuals > 2 > income Statement > net Income
-123663044
Annuals > 2 > income Statement > eps
-2.7588826483514923
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
44823597
Annuals > 2 > income Statement > income Tax Expense
-1956
Annuals > 2 > income Statement > EBITDA
-119154000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1956000
Annuals > 2 > balance Sheet > cash
95272000
Annuals > 2 > balance Sheet > short Term Investments
91255000
Annuals > 2 > balance Sheet > receivables
2245000
Annuals > 2 > balance Sheet > inventories
-19948000
Annuals > 2 > balance Sheet > total Current Assets
193754000
Annuals > 2 > balance Sheet > property Plant Equipment
62695000
Annuals > 2 > balance Sheet > total Assets
278945000
Annuals > 2 > balance Sheet > payables
9578000
Annuals > 2 > balance Sheet > short Term Debt
4006000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
35569000
Annuals > 2 > balance Sheet > equity
243376000
Annuals > 2 > cash Flow > net Income
-123665000
Annuals > 2 > cash Flow > depreciation
6467000
Annuals > 2 > cash Flow > change In Working Capital
-849000
Annuals > 2 > cash Flow > cash From Operations
-104424000
Annuals > 2 > cash Flow > capital Expenditures
20630000
Annuals > 2 > cash Flow > cash From Investing
83652000
Annuals > 2 > cash Flow > cash From Financing
77767000
Annuals > 2 > cash Flow > net Change In Cash
56995000
Annuals > 2 > ratios > PE
-2.7588826483514923
Annuals > 2 > ratios > PB
0.24495177835941095
Annuals > 2 > ratios > ROE
-50.81151962395635
Annuals > 2 > ratios > ROA
-44.332411048773054
Annuals > 2 > ratios > FCF
-125054000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
4025000
Annuals > 3 > income Statement > gross Profit
-4025000
Annuals > 3 > income Statement > operating Expenses
72806000
Annuals > 3 > income Statement > operating Income
-72806000
Annuals > 3 > income Statement > interest Expense
72733279
Annuals > 3 > income Statement > pretax Income
-72721000
Annuals > 3 > income Statement > net Income
-69652000
Annuals > 3 > income Statement > eps
-1.6868414211646239
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
41291374
Annuals > 3 > income Statement > income Tax Expense
-3069000
Annuals > 3 > income Statement > EBITDA
-69845000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
85000
Annuals > 3 > balance Sheet > cash
38129000
Annuals > 3 > balance Sheet > short Term Investments
213171000
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
255358000
Annuals > 3 > balance Sheet > property Plant Equipment
54705000
Annuals > 3 > balance Sheet > total Assets
316647000
Annuals > 3 > balance Sheet > payables
10721000
Annuals > 3 > balance Sheet > short Term Debt
1994000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
38121000
Annuals > 3 > balance Sheet > equity
278526000
Annuals > 3 > cash Flow > net Income
-72721000
Annuals > 3 > cash Flow > depreciation
2961000
Annuals > 3 > cash Flow > change In Working Capital
4742000
Annuals > 3 > cash Flow > cash From Operations
-60812000
Annuals > 3 > cash Flow > capital Expenditures
25121000
Annuals > 3 > cash Flow > cash From Investing
-238564000
Annuals > 3 > cash Flow > cash From Financing
208970000
Annuals > 3 > cash Flow > net Change In Cash
-90406000
Annuals > 3 > ratios > PE
-1.6868414211646239
Annuals > 3 > ratios > PB
0.19717199622297382
Annuals > 3 > ratios > ROE
-25.007360174633607
Annuals > 3 > ratios > ROA
-21.996734534039483
Annuals > 3 > ratios > FCF
-85933000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.12412304847039632
Valuation > metrics > PB
1.6754848216440605
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-24.46662161509871
Profitability > metrics > ROA
-33.107986740475845
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.26683400106192984
Risk > metrics > Interest Coverage
-11.231759656652361
Risk > final Score
15
Risk > verdict
High
Liquidity > metrics > Current Ratio
10.615184607384295
Liquidity > metrics > Quick Ratio
10.615184607384295
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
14
Prev Risks > 1
5
Prev Risks > 2
-17
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2025-12-14T01:19:07.122Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-24
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.1442
Earnings History > 0 > eps Difference
0.1442
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-10
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.12
Earnings History > 1 > eps Estimate
-0.15
Earnings History > 1 > eps Difference
0.03
Earnings History > 1 > surprise Percent
20
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-06
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.14
Earnings History > 2 > eps Estimate
-0.18
Earnings History > 2 > eps Difference
0.04
Earnings History > 2 > surprise Percent
22.2222
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-07
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.24
Earnings History > 3 > eps Estimate
-0.19
Earnings History > 3 > eps Difference
-0.05
Earnings History > 3 > surprise Percent
-26.3158
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-10
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.28
Earnings History > 4 > eps Estimate
-0.31
Earnings History > 4 > eps Difference
0.03
Earnings History > 4 > surprise Percent
9.6774
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-06
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.3
Earnings History > 5 > eps Estimate
-0.37
Earnings History > 5 > eps Difference
0.07
Earnings History > 5 > surprise Percent
18.9189
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-09
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.34
Earnings History > 6 > eps Estimate
-0.39
Earnings History > 6 > eps Difference
0.05
Earnings History > 6 > surprise Percent
12.8205
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-14
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.4
Earnings History > 7 > eps Estimate
-0.42
Earnings History > 7 > eps Difference
0.02
Earnings History > 7 > surprise Percent
4.7619
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-18
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.4
Earnings History > 8 > eps Estimate
-0.44
Earnings History > 8 > eps Difference
0.04
Earnings History > 8 > surprise Percent
9.0909
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-08
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.39
Earnings History > 9 > eps Estimate
-0.47
Earnings History > 9 > eps Difference
0.08
Earnings History > 9 > surprise Percent
17.0213
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-09
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.45
Earnings History > 10 > eps Estimate
-0.5
Earnings History > 10 > eps Difference
0.05
Earnings History > 10 > surprise Percent
10
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-10
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.43
Earnings History > 11 > eps Estimate
-0.56
Earnings History > 11 > eps Difference
0.13
Earnings History > 11 > surprise Percent
23.2143
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-08
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.61
Earnings History > 12 > eps Estimate
-0.65
Earnings History > 12 > eps Difference
0.04
Earnings History > 12 > surprise Percent
6.1538
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-10
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.74
Earnings History > 13 > eps Estimate
-0.64
Earnings History > 13 > eps Difference
-0.1
Earnings History > 13 > surprise Percent
-15.625
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-10
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.69
Earnings History > 14 > eps Estimate
-0.76
Earnings History > 14 > eps Difference
0.07
Earnings History > 14 > surprise Percent
9.2105
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-11
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.75
Earnings History > 15 > eps Estimate
-0.64
Earnings History > 15 > eps Difference
-0.11
Earnings History > 15 > surprise Percent
-17.1875
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-23
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.63
Earnings History > 16 > eps Estimate
-0.6
Earnings History > 16 > eps Difference
-0.03
Earnings History > 16 > surprise Percent
-5
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
AfterMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.68
Earnings History > 17 > eps Estimate
-0.7
Earnings History > 17 > eps Difference
0.02
Earnings History > 17 > surprise Percent
2.8571
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-09-08
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-13.26
Earnings History > 18 > eps Estimate
-7.17
Earnings History > 18 > eps Difference
-6.09
Earnings History > 18 > surprise Percent
-84.9372
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-06-02
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.4
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.4
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2021-03-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-11.9309
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-11.9309
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2019-12-31
Earnings History > 21 > report Date
2020-03-31
Earnings History > 21 > date
2019-12-31
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-10.1469
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-10.1469
Earnings History > 21 > surprise Percent
-
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. The company's lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in phase 2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in phase 1 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. It also develops an adeno-associated virus-based gene therapy designed to deliver the dworf gene for patient with dilated cardiomyopathy; and reprogramming program for heart failure due to prior myocardial infarction. The company develops its products through gene editing, cellular regeneration, gene silencing, and gene addition. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATenaya Therapeutics (TNYA) Is Down 39.7% After Cardiac Gene Therapy Milestones And $60M Fundraise - What's Changed Yahoo Finance
Read more →Tenaya Therapeutics (NASDAQ:TNYA) Given New $3.00 Price Target at HC Wainwright - MarketBeat
12/13/2025
Tenaya Therapeutics (NASDAQ:TNYA) Given New $3.00 Price Target at HC Wainwright MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$10.1429
Analyst Picks
Strong Buy
6
Buy
3
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 21.57% of the total shares of Tenaya Therapeutics Inc
1.
Column Group LLC(5.7679%)
since
2025/06/30
2.
Vanguard Group Inc(2.9178%)
since
2025/06/30
3.
Vanguard Total Stock Mkt Idx Inv(1.7293%)
since
2025/07/31
4.
BlackRock Inc(1.6768%)
since
2025/06/30
5.
Renaissance Technologies Corp(1.1314%)
since
2025/06/30
6.
AQR Capital Management LLC(1.069%)
since
2025/06/30
7.
Vanguard Institutional Extnd Mkt Idx Tr(0.7572%)
since
2025/07/31
8.
Geode Capital Management, LLC(0.7551%)
since
2025/06/30
9.
Euclidean Capital LLC(0.6232%)
since
2025/06/30
10.
Alphabet Inc(0.5619%)
since
2025/06/30
11.
Millennium Management LLC(0.4177%)
since
2025/06/30
12.
Aberdeen Group PLC(0.3686%)
since
2025/06/30
13.
abrdn Life Sciences Investors(0.3686%)
since
2025/08/31
14.
Fidelity Extended Market Index(0.3359%)
since
2025/07/31
15.
Two Sigma Investments LLC(0.2913%)
since
2025/06/30
16.
StepStone Group LLC(0.2836%)
since
2025/06/30
17.
Squarepoint Ops LLC(0.2355%)
since
2025/06/30
18.
Jane Street Group LLC(0.2308%)
since
2025/06/30
19.
Casdin Capital, LLC(0.2221%)
since
2025/06/30
20.
Susquehanna International Group, LLP(0.1895%)
since
2025/06/30
21.
Royal Bank of Canada(0.1806%)
since
2025/06/30
22.
Trustees Of Columbia University In The City Of New York(0.1791%)
since
2025/06/30
23.
Goldman Sachs Group Inc(0.1719%)
since
2025/06/30
24.
Vifag 2002 SICAV(0.1534%)
since
2025/07/31
25.
State Street Corp(0.1287%)
since
2025/06/30
26.
Fidelity Total Market Index(0.1078%)
since
2025/07/31
27.
Fidelity Nasdaq Composite Index(0.0959%)
since
2025/07/31
28.
Fidelity Series Total Market Index(0.0912%)
since
2025/07/31
29.
Galileo - Biotech Innovation Fund S USD(0.0791%)
since
2025/02/28
30.
Spartan Extended Market Index Pool F(0.0737%)
since
2025/07/31
31.
Extended Equity Market Fund K(0.0671%)
since
2025/06/30
32.
Spartan Total Market Index Pool G(0.0504%)
since
2025/07/31
33.
NT Ext Equity Mkt Idx Fd - L(0.0392%)
since
2025/06/30
34.
Northern Trust Extended Eq Market Idx(0.0392%)
since
2025/06/30
35.
Vanguard Balanced Index Inv(0.0359%)
since
2025/07/31
36.
Goldman Sachs Absolute Ret Trckr Instl(0.0341%)
since
2025/06/30
37.
NT Ext Equity Mkt Idx Fd - NL(0.0293%)
since
2025/06/30
38.
AST Small Cap Value(0.0282%)
since
2024/11/30
39.
NT Col R2000 Val Idx Fd -DC -L -TierFour(0.0272%)
since
2025/03/31
40.
Vanguard Instl Ttl Stck Mkt Idx Tr(0.026%)
since
2024/12/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.1442
Date
2025-09-30
EPS Actual
-0.12
EPS Estimate
-0.15
EPS Difference
0.03
Surprise Percent
20%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.